Global Lung Cancer Liquid Biopsy Market Research Report 2024(Status and Outlook)

Global Lung Cancer Liquid Biopsy Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Lung Cancer Liquid Biopsy Market Size was estimated at USD 194.35 million in 2023 and is projected to reach USD 426.59 million by 2029, exhibiting a CAGR of 14.00% during the forecast period.

This report provides a deep insight into the global Lung Cancer Liquid Biopsy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Liquid Biopsy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Liquid Biopsy market in any manner.

Global Lung Cancer Liquid Biopsy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

RainDanceTechnologies

Biocartis

Qiagen

Guardant Health

MDxHealth

Pathway Genomics

NeoGenomics Laboraories

Sysmex Inostics

Cynvenio

Menarini Silicon Biosystems

Adaptive Biotechnologies

Biocept

Angle plc

Market Segmentation (by Type)

Exosomes and RNA

CTCs and ctDNA

Market Segmentation (by Application)

Hospitals

Clinics

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Lung Cancer Liquid Biopsy Market

Overview of the regional outlook of the Lung Cancer Liquid Biopsy Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Liquid Biopsy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Lung Cancer Liquid Biopsy
1.2 Key Market Segments
1.2.1 Lung Cancer Liquid Biopsy Segment by Type
1.2.2 Lung Cancer Liquid Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Lung Cancer Liquid Biopsy Market Overview
2.1 Global Market Overview
2.1.1 Global Lung Cancer Liquid Biopsy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lung Cancer Liquid Biopsy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Lung Cancer Liquid Biopsy Market Competitive Landscape
3.1 Global Lung Cancer Liquid Biopsy Sales by Manufacturers (2019-2024)
3.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Manufacturers (2019-2024)
3.3 Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lung Cancer Liquid Biopsy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lung Cancer Liquid Biopsy Sales Sites, Area Served, Product Type
3.6 Lung Cancer Liquid Biopsy Market Competitive Situation and Trends
3.6.1 Lung Cancer Liquid Biopsy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Liquid Biopsy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Lung Cancer Liquid Biopsy Industry Chain Analysis
4.1 Lung Cancer Liquid Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Lung Cancer Liquid Biopsy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Lung Cancer Liquid Biopsy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Liquid Biopsy Sales Market Share by Type (2019-2024)
6.3 Global Lung Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
6.4 Global Lung Cancer Liquid Biopsy Price by Type (2019-2024)
7 Lung Cancer Liquid Biopsy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Liquid Biopsy Market Sales by Application (2019-2024)
7.3 Global Lung Cancer Liquid Biopsy Market Size (M USD) by Application (2019-2024)
7.4 Global Lung Cancer Liquid Biopsy Sales Growth Rate by Application (2019-2024)
8 Lung Cancer Liquid Biopsy Market Segmentation by Region
8.1 Global Lung Cancer Liquid Biopsy Sales by Region
8.1.1 Global Lung Cancer Liquid Biopsy Sales by Region
8.1.2 Global Lung Cancer Liquid Biopsy Sales Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Liquid Biopsy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Liquid Biopsy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Liquid Biopsy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Liquid Biopsy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Liquid Biopsy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 RainDanceTechnologies
9.1.1 RainDanceTechnologies Lung Cancer Liquid Biopsy Basic Information
9.1.2 RainDanceTechnologies Lung Cancer Liquid Biopsy Product Overview
9.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Product Market Performance
9.1.4 RainDanceTechnologies Business Overview
9.1.5 RainDanceTechnologies Lung Cancer Liquid Biopsy SWOT Analysis
9.1.6 RainDanceTechnologies Recent Developments
9.2 Biocartis
9.2.1 Biocartis Lung Cancer Liquid Biopsy Basic Information
9.2.2 Biocartis Lung Cancer Liquid Biopsy Product Overview
9.2.3 Biocartis Lung Cancer Liquid Biopsy Product Market Performance
9.2.4 Biocartis Business Overview
9.2.5 Biocartis Lung Cancer Liquid Biopsy SWOT Analysis
9.2.6 Biocartis Recent Developments
9.3 Qiagen
9.3.1 Qiagen Lung Cancer Liquid Biopsy Basic Information
9.3.2 Qiagen Lung Cancer Liquid Biopsy Product Overview
9.3.3 Qiagen Lung Cancer Liquid Biopsy Product Market Performance
9.3.4 Qiagen Lung Cancer Liquid Biopsy SWOT Analysis
9.3.5 Qiagen Business Overview
9.3.6 Qiagen Recent Developments
9.4 Guardant Health
9.4.1 Guardant Health Lung Cancer Liquid Biopsy Basic Information
9.4.2 Guardant Health Lung Cancer Liquid Biopsy Product Overview
9.4.3 Guardant Health Lung Cancer Liquid Biopsy Product Market Performance
9.4.4 Guardant Health Business Overview
9.4.5 Guardant Health Recent Developments
9.5 MDxHealth
9.5.1 MDxHealth Lung Cancer Liquid Biopsy Basic Information
9.5.2 MDxHealth Lung Cancer Liquid Biopsy Product Overview
9.5.3 MDxHealth Lung Cancer Liquid Biopsy Product Market Performance
9.5.4 MDxHealth Business Overview
9.5.5 MDxHealth Recent Developments
9.6 Pathway Genomics
9.6.1 Pathway Genomics Lung Cancer Liquid Biopsy Basic Information
9.6.2 Pathway Genomics Lung Cancer Liquid Biopsy Product Overview
9.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Product Market Performance
9.6.4 Pathway Genomics Business Overview
9.6.5 Pathway Genomics Recent Developments
9.7 NeoGenomics Laboraories
9.7.1 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Basic Information
9.7.2 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product Overview
9.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product Market Performance
9.7.4 NeoGenomics Laboraories Business Overview
9.7.5 NeoGenomics Laboraories Recent Developments
9.8 Sysmex Inostics
9.8.1 Sysmex Inostics Lung Cancer Liquid Biopsy Basic Information
9.8.2 Sysmex Inostics Lung Cancer Liquid Biopsy Product Overview
9.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Product Market Performance
9.8.4 Sysmex Inostics Business Overview
9.8.5 Sysmex Inostics Recent Developments
9.9 Cynvenio
9.9.1 Cynvenio Lung Cancer Liquid Biopsy Basic Information
9.9.2 Cynvenio Lung Cancer Liquid Biopsy Product Overview
9.9.3 Cynvenio Lung Cancer Liquid Biopsy Product Market Performance
9.9.4 Cynvenio Business Overview
9.9.5 Cynvenio Recent Developments
9.10 Menarini Silicon Biosystems
9.10.1 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Basic Information
9.10.2 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product Overview
9.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product Market Performance
9.10.4 Menarini Silicon Biosystems Business Overview
9.10.5 Menarini Silicon Biosystems Recent Developments
9.11 Adaptive Biotechnologies
9.11.1 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Basic Information
9.11.2 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product Overview
9.11.3 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product Market Performance
9.11.4 Adaptive Biotechnologies Business Overview
9.11.5 Adaptive Biotechnologies Recent Developments
9.12 Biocept
9.12.1 Biocept Lung Cancer Liquid Biopsy Basic Information
9.12.2 Biocept Lung Cancer Liquid Biopsy Product Overview
9.12.3 Biocept Lung Cancer Liquid Biopsy Product Market Performance
9.12.4 Biocept Business Overview
9.12.5 Biocept Recent Developments
9.13 Angle plc
9.13.1 Angle plc Lung Cancer Liquid Biopsy Basic Information
9.13.2 Angle plc Lung Cancer Liquid Biopsy Product Overview
9.13.3 Angle plc Lung Cancer Liquid Biopsy Product Market Performance
9.13.4 Angle plc Business Overview
9.13.5 Angle plc Recent Developments
10 Lung Cancer Liquid Biopsy Market Forecast by Region
10.1 Global Lung Cancer Liquid Biopsy Market Size Forecast
10.2 Global Lung Cancer Liquid Biopsy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Liquid Biopsy Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Liquid Biopsy Market Size Forecast by Region
10.2.4 South America Lung Cancer Liquid Biopsy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Liquid Biopsy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Lung Cancer Liquid Biopsy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lung Cancer Liquid Biopsy by Type (2025-2030)
11.1.2 Global Lung Cancer Liquid Biopsy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lung Cancer Liquid Biopsy by Type (2025-2030)
11.2 Global Lung Cancer Liquid Biopsy Market Forecast by Application (2025-2030)
11.2.1 Global Lung Cancer Liquid Biopsy Sales (K Units) Forecast by Application
11.2.2 Global Lung Cancer Liquid Biopsy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings